Concepedia

Publication | Open Access

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

50

Citations

29

References

2020

Year

Abstract

Chinese Clinical Trial Registry (http://www.chictr.org.cn): ChiCTR-OOC-16007779.

References

YearCitations

Page 1